Exploiting Dendrimer Multivalency To Combat Emerging and Re-Emerging Infectious Diseases

被引:132
|
作者
Mintzer, Meredith A. [2 ]
Dane, Eric L. [2 ]
O'Toole, George A. [3 ]
Grinstaff, Mark W. [1 ,2 ]
机构
[1] Boston Univ, Dept Biomed Engn, Metcalf Ctr Sci & Engn, Boston, MA 02215 USA
[2] Boston Univ, Dept Chem, Boston, MA 02215 USA
[3] Dartmouth Med Sch, Dept Microbiol & Immunol, Hanover, NH 03755 USA
基金
美国国家卫生研究院;
关键词
dendrimer; dendritic polymers; bacteria; antimicrobial; infection; antibacterial agents; coatings; carriers; drug delivery; HEAT-LABILE ENTEROTOXIN; OLIGOSACCHARIDE-DERIVATIZED DENDRIMERS; LIPOSOME-ENCAPSULATED GENTAMICIN; POLY(PROPYLENE IMINE) DENDRIMERS; GUINEA-PIG MODEL; TOXIN-B-SUBUNIT; ESCHERICHIA-COLI; CHOLERA-TOXIN; ANTIMICROBIAL POLYMERS; POLY(AMIDOAMINE) DENDRIMERS;
D O I
10.1021/mp2005033
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The emergence and re-emergence of bacterial strains that are resistant to current antibiotics reveal the clinical need for new agents that possess broad-spectrum antibacterial activity. Furthermore, bacteriophobic coatings that repel bacteria are important for medical devices, as the lifetime, reliability, and performance of implant devices are hindered by bacterial adhesion and infection. Dendrimers, a specific class of monodisperse macromolecules, have recently shown potential to function as both antibacterial agents and antimicrobial surface coatings. This review discusses the limitations with currently used antibacterial agents and describes how various classes of dendrimers, including glycodendrimers, cationic dendrimers, anionic dendrimers, and peptide dendrimers, have the potential to improve upon or replace certain antibiotics. Furthermore, the unexplored areas in this field of research will be mentioned to present opportunities for additional studies regarding the use of dendrimers as antimicrobial agents.
引用
收藏
页码:342 / 354
页数:13
相关论文
共 50 条
  • [1] Emerging and re-emerging infectious diseases
    Macintire, DK
    Breitschwerdt, EB
    VETERINARY CLINICS OF NORTH AMERICA-SMALL ANIMAL PRACTICE, 2003, 33 (04) : XI - XIII
  • [2] Emerging and re-emerging infectious diseases
    Heinz Feldmann
    Markus Czub
    Steven Jones
    Daryl Dick
    Michael Garbutt
    Allen Grolla
    Harvey Artsob
    Medical Microbiology and Immunology, 2002, 191 : 63 - 74
  • [3] Emerging and re-emerging infectious diseases
    Desselberger, U
    JOURNAL OF INFECTION, 2000, 40 (01) : 3 - 15
  • [4] Emerging and re-emerging infectious diseases
    不详
    MIDWIFERY, 1998, 14 (04) : 267 - 268
  • [5] Emerging and re-emerging infectious diseases
    Feldmann, H
    Czub, M
    Jones, S
    Dick, D
    Garbutt, M
    Grolla, A
    Artsob, H
    MEDICAL MICROBIOLOGY AND IMMUNOLOGY, 2002, 191 (02) : 63 - 74
  • [6] Emerging and re-emerging infectious diseases
    Peetermans, W. E.
    De Munter, P.
    ACTA CLINICA BELGICA, 2007, 62 (05): : 337 - 341
  • [7] The challenge of emerging and re-emerging infectious diseases
    David M. Morens
    Gregory K. Folkers
    Anthony S. Fauci
    Nature, 2004, 430 : 242 - 249
  • [8] Determinants of emerging and re-emerging infectious diseases
    Nicastri, E
    Girardi, E
    Ippolito, G
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2001, 15 (03): : 212 - 217
  • [9] Newly emerging and re-emerging infectious diseases
    Kotulová, D
    Slobodníková, L
    BIOLOGIA, 2001, 56 : 3 - 7
  • [10] The challenge of emerging and re-emerging infectious diseases
    Morens, DM
    Folkers, GK
    Fauci, AS
    NATURE, 2004, 430 (6996) : 242 - 249